Uncovering Unique Effects in Preclinical Alzheimer's Disease with Digital Cognition

Abstract

By definition, there are no overt cognitive changes in the preclinical stages of Alzheimer's disease (AD). Technologies for cognitive assessments have evolved to such a degree that they are more than digital substitutes for conventional tests and can reveal unique aspects of cognitive changes in AD prior to symptom onset.